• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Revance Therapeutics Inc

+ Add to Watchlist

RVNC:US

16.7900 USD 0.1400 0.84%

As of 20:10:00 ET on 12/26/2014.

Company Profile for Revance Therapeutics Inc (RVNC)

Revance Therapeutics, Inc. produces biopharmaceutical products. The Company develops drug delivery and treatments for dermatology and aesthetic medicine. Revance Therapeutics serves patients and doctors throughout the United States.

Contact Information

Revance Therapeutics Inc

PO Box 303
Newark, CA 94560-0303
United States
Phone: 1-510-742-3400
Fax: 1-510-742-3401

Key Executives for Revance Therapeutics Inc (RVNC)

L Daniel Browne "Dan"President/CEO/Co-FounderJacob WaughChief Scientific Ofcr/Dir:Medical
Arthur P BertolinoExec VP/Chief Medical OfficerLauren P SilvernailExec VP:Corporate Dev/CFO
Curtis RueggExec VP:Research & DevNiquette HuntSenior VP:Commercial Dev
David StykaSenior VP:FinanceSharon HallVP:Regulatory Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil